Diabetes mellitus: Metabolic effects and oxidative stress

Biologicheskie Membrany

Volumn 28, Issue 2, 2011, Pages 83-94

  Zavodnik, I B ^a,b   Dremza, K ^a   Lapshina, E A ^a   Cheshchevik, V T ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Belarus)

^b YANKA KUPALA STATE UNIVERSITY OF GRODNO   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958126147     PISSN: 02334755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Brownlee M. 2005. Banting Lecture 2004. The pathobiology of diabetic complications. A unifying mechanism. Diabetes. 54, 1615-1625. (Pubitemid 40770750)
2. Bojunga J., Dresar-Mayert B., Usadel K.-H., Kusteter K., Zeuzem S. 2004. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats. Biochem. Biophys. Res. Commun. 316, 771-780. (Pubitemid 38368020)
3. Vfolff S.P., Dean R. T. 1987.Glucose autoxidation and protein modification: the potential role of "autoxidative glucosylation" in diabetes. Biochem. J. 245, 243-250. (Pubitemid 17089839)
4. Wolff, S.P., Jiang Z.Y., Hunt J. V. 1991. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radio. Biol. Med. 10, 339-352. (Pubitemid 121003905)
5. Baynes J.W. 2004. The clinical chemome: A tool for the diagnosis and management of chronic disease. Clin. Chem. 50 (7), 1116-1117. (Pubitemid 38824220)
6. Thorpe S.R., Baynes J.M. 2002. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids. 25, 275-281.
7. Gerbitz K.D., Gempel K., Brdiczka D. 1996. Mitochondria and diabetes. Genetic, biochemical, and clin- RMP ical implications of the cellular energy circuit. Diabetes. 45(2), 113-126.
8. Beyer T.A., Hutson N.J. 1986. Introduction: Evidence for the role of the polyol pathway in the pathophysiology of diabetic complications. Metabolism. 35, 1-3. (Pubitemid 16104314)
9. Hamada Y., Nishimura C, Koh N., Sakakibara R, Nakamura J., Tanimoto T, Hotta N. 1998. Influence of interindividual variability of aldose reductase protein content on polyol-pathway metabolites and redox state in erythrocytes in diabetic patients. Diabetes Care. 21, 1014-1018. (Pubitemid 28488798)
10. Chung S.S., Chung S.K. 2003. Genetic analysis of aldose reductase in diabetic complications. Curr. Med. Chem. 10, 1375-1387. (Pubitemid 36903154)
11. Ulrich P., Cerami A. 2001. Protein glycation, diabetes, and aging. Recent Prog. Horm. Res. 56, 1-21.
12. Morgan D., Oliveira-Emilio H.R., Keane D., Hirata A.E., Santos da Rocha M., Bordin S., Curi R., Newsholme E, Carpinelli A.R. 2007. Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal p cell line. Diabetologia. 50, 359-369.
13. DuX.L, Edelstein D., Rossetti L, Fantus I.G., Goldberg H., Ziyadeh E, Wu J., Brownlee M. 2000. Hyperglycemiainduced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Spl glycosylation. Proc. Natl. Acad. Sci. USA. 97, 12222-12226.
14. James L.R., Tang D., Ingram A., Ly H., Thai K., Cai L., Scholey J.W. 2002. Flux through the hexosamine pathway is a determinant of nuclear factor i n dependent promoter activation. Diabetes. 51, 1146-1156. (Pubitemid 34438362)
15. Goldberg H.J., Whiteside C.I., Fantus I.G. 2002. The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Spl transcriptional activation through protein kinase C-P I and -8. J . Biol. Chem. Ill, 33833-33841.
16. Nisikawa T, Edelstein D., Du X. L., Yamagishi S., Matsumura T, Kaneda Y, Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., Brownlee M. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 404, 787-790. (Pubitemid 30212409)
17. Brownlee M. 1995. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46, 223-234.
18. Stevens M.J., Obrosova I., Feldman E.L., Greene D.A. 2000. The sorbitol-osmotic and sorbitol-redox hypothesis. Diabetes Mellitus:A Fundamental and Clinical Text. Eds LeRoith D., Taylor S.I., Olefsky J.M. Philadelphia: Lippincott Williams & Wilkins, P. 972-983.
19. Barnes P.J., Karin M. 1997. Nuclear factor kappa B: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066-1071. (Pubitemid 27163860)
20. Moxamed A.K., Bierhaus A., Schiekofer S., Tritschler H., Ziegler R., Nawroth P.P. 1999. The role of oxidative stress and NF-kB activation in late diabetic complications. Biofactors. 10,157-167. (Pubitemid 29533824)
21. Evans J.L., Goldfine I.D., Maddux BA, Grodsky G.M. 2003. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction. Diabetes. 52, 1-8. (Pubitemid 36042100)
22. Evans J.L., Maddux B.A., Goldfine I.D. 2005. The molecular basis for oxidative stress-induced insulin resistence. Antioxid. Redox Signal. 7,1040-1052. (Pubitemid 40967154)
23. Birnbaum M.J. 2001. Turning down insulin signaling. J . Clin. Invest. 108, 655-659. (Pubitemid 32906191)
24. 2 -terminal kinase promotes insulin resistance during association with insulin receptor substrate- 1 and phosphorylation of Ser (307). J . Biol. Chem. 275, 9047-9054. (Pubitemid 30180265)
25. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W, Karin M., Shoelson S.E. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science. 293, 1673-1677. (Pubitemid 32807849)
26. Sudnikovich EJu., Maksimchik Yu.Z., Zabrodskaya S.V, Kubyshin VL, Lapshina EA, Bryszewska M., Reiter RJ., Zavodnik I.B. 2007. Melatonin attenuates metabolic disorders due to streptozotocin-induced diabetes in rats. Eur. J. Pharmacol. 569,180-187. (Pubitemid 47208514)
27. Evans J.L., Lin J.J., Goldfine I.D. 2005. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARa, PPARy and PPAR8. Curr. Diabetes Rev. 1, 299-307.
28. Evans J.L., Maddux B.A., Goldfine I.D. 2005. The molecular basic for oxidative stress-induced insulin resistance. Antioxid. Redox Signal. 7, 1040-1052. (Pubitemid 40967154)
29. Bevan P. 2001. Insulin signaling. J . CellSci. 114,1429-1430.
30. Kim J., Wei Y, Sowers J.R. 2008. Role of mitochondrial dysfunction in insulin resistance. Ore. Res. 102, 401-414. (Pubitemid 351651099)
31. Cantley L.C. 2002. The phosphoinositide 3-kinase pathway. Science. 296, 1655-1657. (Pubitemid 34579158)
32. Sedaghat A.R., Sherman A., Quon M.J. 2002. A mathematical model of metabolic insulin signaling pathways. Am. J. Physiol. Endocrinol. Metab. 283, 1084-1101.
33. Sowers J.R. 2007. Insulin resistance and hypertension. Am. J. Phiysiol. Heart Circ. Physiol. 293, 2009-2020.
34. McGarry J.D. 2002. Banting Lecture 2001. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 51, 7-18.
35. Matschinsky F.M. 1996. Banting lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes. 45 (2), 223-241. (Pubitemid 26045806)
36. Newsholme R, HaberE.R, Hirabara S.M., Rebelato E.L.O., Procopio J., Morgan D., Oliveira-Emilio H.C., Carpinelli A.R., Curi R. 2007. Diabetes associated cell stress and dysfunction: Role of mitochondrial and non-mitochondrial ROS production and activity. J . Physiol. 583 (1), 9-24. (Pubitemid 47244241)
37. Newsholme P., Brennan L., Bender K. 2006. Amino acid metabolism, β-cell function, and diabetes. Diabetes. 55 (Suppl. 2), 39-47.
38. Babior B.M. 1999. NADPH oxidase: an update. Blood. 93, 1464-1476. (Pubitemid 29102471)
39. Yoshioka N., Adachi J, Ueno Y, Yoshida K. 2005. Oxysterols increase in diabetic rats. Free Radic. Res. 39, 299-304. (Pubitemid 40439392)
40. Irani K. 2000. Oxidant signaling in vascular cell growth, death, and survival: A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87,179-183. (Pubitemid 30626423)
41. 'Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease Int. J. Biochem. Cell. Biol. 39, 44-84. (Pubitemid 44566469)
42. Schoonbroodt S., Piette J. 2000. Oxidative stress interference with the nuclear factor-K B activation pathways. Biochem. Pharmacol. 60, 1075-1083.
43. Taylor A.J., Ye J.M., Schmitz-Peiffer C. 2006. Inhibition of glycogen synthesis by increased lipid availability is associated with subcellular redistribution of glycogen synthase. J . Endocrinol. 188, 11-23. (Pubitemid 43159806)
44. Fridlyand L.E., Philipson L.H. 2005. Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches. Ann. NY Acad. Sci. 1066, 136-151.
45. Katakam A.K., Chipitsyna G., Gong Q., \kncha A.R., Gabbeta J., Arafat H.A. 2005. Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): A novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production. J . Endocrinol. 187, 237-247. (Pubitemid 41685183)
46. SalnielA.R., KahnC.R. 2001. Insulin signaling and the regulation of glucose and lipid metabolism. Nature. 414, 799-806. (Pubitemid 34000783)
47. Zhande R., Mitchell J.J., Wu J., Sun X.J. 2002. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol. Cell. Biol. 22, 1016-1026. (Pubitemid 34094839)
48. Vinciguerra M., Foti M. 2006. PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signaling. Arch. Physiol. Biochem. 112, 89-104. (Pubitemid 44384777)
49. Senn J.J. 2006. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J . Biol. Chem. 281, 26865-26875. (Pubitemid 44401715)
50. Morino K., Petersen KLF, Dufour S., Befroy D., Frattini J., Shatzkes N., Neschen S.,White M.F., Bilz S., Sono S., Pypaert M., Shulman G.I. 2005. Reduced mitochondrial density and increased 1RS-1 serine phosphorylation in muscle of type 2 diabetic parents. J . Clin. Invest. 115, 3587-3593. (Pubitemid 43121847)
51. Nishikawa T, Araki E. 2007. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid. Redox. Signal. 9, 343-353. (Pubitemid 46150966)
52. Itani S.I., Ruderman N.B., Schmieder R, Boden G. 2002. A central role for JNK in obesity and insulin re- 2002. Lipid-induced insulin resistance in human mus- sistance. Nature. 420, 333-336. cle is associated with changes in diacylglycerol, protein
53. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z.,Uysal K.T., Maeda K., Karin M., Hotamisligil G.S.2002. A central role for JNK in obesity and insulin resistance. Nature. 420, 333-336. (Pubitemid 35398190)
54. Burks D.J., White M.F. 2001. IRS proteins and β-cell function . Diabetes. 50 (Suppl. 1), 140-145.
55. Paris M., Bernard-Kargar C, Vilar J., Kassis N., Ktorza A. 2004. Role of glucose in IRS signaling in rat pan-creatic islets: Specific effects and interplay with insulin. Exp. Diabesity Res. 5,257-263. (Pubitemid 40123410)